Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Woodchuck Hepatitis Virus Post-Transcriptional Regulation Element (WPRE) Promotes Anti-CD19 BiTE Expression in Expi293 Cells.
Iran Biomed J. 2021 Jul 1;25(4):275-83. doi: 10.52547/ibj.25.4.275. Epub 2021 May 19.
Iran Biomed J. 2021.
PMID: 34217158
Free PMC article.
Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor.
Hassani M, Hajari Taheri F, Sharifzadeh Z, Arashkia A, Hadjati J, van Weerden WM, Abdoli S, Modarressi MH, Abolhassani M.
Hassani M, et al. Among authors: hajari taheri f.
Iran Biomed J. 2020 Mar;24(2):81-8. doi: 10.29252/ibj.24.2.81. Epub 2019 Oct 23.
Iran Biomed J. 2020.
PMID: 31677604
Free PMC article.
Item in Clipboard
The effect of Candida albicans systemic infection on matrix metalloproteinases in breast cancer bearing BALB/c mice.
Hajari Taheri F, Seyedolmohadesin M, Bayat M, Mahdavi M, Yazdi MH, Eslamifar A, Abolhasani M.
Hajari Taheri F, et al.
Iran J Allergy Asthma Immunol. 2013 Mar;12(1):81-5.
Iran J Allergy Asthma Immunol. 2013.
PMID: 23454783
Free article.
Item in Clipboard
Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapy.
Bahrololoumi Shapourabadi M, Momburg F, Roohvand F, Jarahian M, Mohajel N, Arashkia A, Hajari Taheri F, Abbasalipour M, Azadmanesh K.
Bahrololoumi Shapourabadi M, et al. Among authors: hajari taheri f.
Int Immunopharmacol. 2021 Jul;96:107762. doi: 10.1016/j.intimp.2021.107762. Epub 2021 May 31.
Int Immunopharmacol. 2021.
PMID: 34162140
Item in Clipboard
T cell engineered with a novel nanobody-based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy.
Hajari Taheri F, Hassani M, Sharifzadeh Z, Behdani M, Arashkia A, Abolhassani M.
Hajari Taheri F, et al.
IUBMB Life. 2019 Sep;71(9):1259-1267. doi: 10.1002/iub.2019. Epub 2019 Feb 6.
IUBMB Life. 2019.
PMID: 30724452
Free article.
Item in Clipboard
Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer.
Hassani M, Hajari Taheri F, Sharifzadeh Z, Arashkia A, Hadjati J, van Weerden WM, Modarressi MH, Abolhassani M.
Hassani M, et al. Among authors: hajari taheri f.
J Cell Biochem. 2019 Jun;120(6):10787-10795. doi: 10.1002/jcb.28370. Epub 2019 Jan 22.
J Cell Biochem. 2019.
PMID: 30672018
Item in Clipboard
Cite
Cite